We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current ALCJ market cap is 75.73M. The company's latest EPS is EUR -0.3035 and P/E is -6.79.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 456k | 2.05M | 424k | 1.15M | 3.14M |
| Operating Income | -11.72M | -8.49M | -10.06M | -11.37M | -12.32M |
| Net Income | -10.71M | -7.17M | -9.84M | -10.81M | -11.16M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 20.16M | 24.49M | 33.59M | 31.53M | 32.86M |
| Total Liabilities | 18.5M | 21.48M | 34.72M | 37.01M | 30.17M |
| Total Equity | 1.66M | 3.01M | -1.13M | -5.48M | 2.69M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -8.02M | -5.51M | -5.46M | -6.08M | -5.08M |
| Investing | -3.27M | -4.4M | -6.1M | -6.73M | -6.78M |
| Financing | 13.3M | 13M | 11.93M | 14.52M | 9.64M |
| Market Cap | 75.73M |
| Price to Earnings Ratio | -6.79 |
| Price to Sales Ratio | 24.15 |
| Price to Cash Ratio | 9.74 |
| Price to Book Ratio | 28.2 |
| Dividend Yield | - |
| Shares Outstanding | 36.76M |
| Average Volume (1 week) | 88.51k |
| Average Volume (1 Month) | 134.06k |
| 52 Week Change | -46.84% |
| 52 Week High | 5.96 |
| 52 Week Low | 1.828 |
| Spread (Intraday) | 0.02 (0.72%) |
| Company Name | Crossject |
| Address |
6 rue pauline kergomard - zac parc mazen sully dijon, cote-d'or 21000 |
| Website | https://www.crossject.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
